EMEA-001539-PIP01-13-M04

Key facts

Invented name
Lokelma
Active substance
sodium zirconium cyclosilicate
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0069/2020
PIP number
EMEA-001539-PIP01-13-M04
Pharmaceutical form(s)
Oral powder
Condition(s) / indication(s)
Treatment of hyperkalaemia
Route(s) of administration
  • Oral use
  • Nasogastric use
Contact for public enquiries
AstraZeneca AB

E-mail: paediatrics@astrazeneca.com
Tel. +46(8)55324400

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating